News | March 31, 2026
Samsung Biologics scores big at 2026 CDMO Leadership Awards
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The FDA approval makes PD-L1 IHC 22C3 pharmDx the only companion diagnostic approved to detect tumors expressing PD-L1 in esophageal or GEJ carcinoma patients for KEYTRUDA treatmen
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
IntraSight Plus enables confident decision-making and better patient care,” Philips said, emphasizing efficiency, simplicity, and precision
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments
Otsuka will pay $700 million to Transcend shareholders at closing, with an additional $525 million in contingent payments tied to future sales milestones
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
Subscribe To Our Newsletter & Stay Updated
